Spyre Therapeutics to Participate in Upcoming Investor Conferences
Globe Newswire•10/11/2026•08:00 ET
0
Key Highlights
- ➤Spyre management to attend four investor conferences in November and December
- ➤Four fireside presentations scheduled across London and Miami conferences
- ➤Spyre management will hold one-on-one investor meetings during conferences
WALTHAM, Mass., Nov. 10, 2026 (GLOBE NEWSWIRE) -- Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company committed to developing next-generation therapies that elevate the standard in immunology by delivering more complete disease control, greater durability, and a simpler treatment experience for patients, today announced that management will participate in the following upcoming investor conferences in November and December:
Event: UBS Global Biopharma Conference – London Date: Monday, November 16, 2026 Fireside Time: 1:20 pm GMT
Get started
Create a free account to read the full story.